Notably, while skeletal dysplasia mutations are distributed throughout the TRPV4 channel, neuromuscular disease-causing mutations (referred to hereafter as neuropathy mutations) are primarily localized to a confined region of the N-terminal cytoplasmic domain. This evidence concerns the gene TRPV4 and neuromuscular disease.